Viewing Study NCT02713295


Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2026-02-18 @ 10:58 AM
Study NCT ID: NCT02713295
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2016-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate to Severe Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate Plaque Psoriasis View
None Severe Plaque Psoriasis View
None Plaque Psoriasis View